nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—ATIC—leg—chronic obstructive pulmonary disease	0.0575	0.193	CbGeAlD
Pemetrexed—GART—respiratory system—chronic obstructive pulmonary disease	0.021	0.0707	CbGeAlD
Pemetrexed—GART—bronchus—chronic obstructive pulmonary disease	0.0173	0.0582	CbGeAlD
Pemetrexed—GART—trachea—chronic obstructive pulmonary disease	0.0156	0.0522	CbGeAlD
Pemetrexed—GART—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.0147	0.081	CbGpPWpGaD
Pemetrexed—ATIC—respiratory system—chronic obstructive pulmonary disease	0.0143	0.048	CbGeAlD
Pemetrexed—ATIC—connective tissue—chronic obstructive pulmonary disease	0.0126	0.0422	CbGeAlD
Pemetrexed—ATIC—smooth muscle tissue—chronic obstructive pulmonary disease	0.0115	0.0386	CbGeAlD
Pemetrexed—GART—lung—chronic obstructive pulmonary disease	0.0112	0.0375	CbGeAlD
Pemetrexed—GART—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00984	0.0544	CbGpPWpGaD
Pemetrexed—TYMS—respiratory system—chronic obstructive pulmonary disease	0.00969	0.0325	CbGeAlD
Pemetrexed—DHFR—respiratory system—chronic obstructive pulmonary disease	0.0096	0.0322	CbGeAlD
Pemetrexed—SLC29A1—respiratory system—chronic obstructive pulmonary disease	0.00869	0.0292	CbGeAlD
Pemetrexed—TYMS—connective tissue—chronic obstructive pulmonary disease	0.00853	0.0287	CbGeAlD
Pemetrexed—DHFR—connective tissue—chronic obstructive pulmonary disease	0.00845	0.0284	CbGeAlD
Pemetrexed—TYMS—bronchus—chronic obstructive pulmonary disease	0.00798	0.0268	CbGeAlD
Pemetrexed—SLC46A1—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00792	0.0437	CbGpPWpGaD
Pemetrexed—DHFR—bronchus—chronic obstructive pulmonary disease	0.0079	0.0265	CbGeAlD
Pemetrexed—TYMS—smooth muscle tissue—chronic obstructive pulmonary disease	0.00781	0.0262	CbGeAlD
Pemetrexed—SLC29A1—connective tissue—chronic obstructive pulmonary disease	0.00765	0.0257	CbGeAlD
Pemetrexed—ATIC—lung—chronic obstructive pulmonary disease	0.00759	0.0255	CbGeAlD
Pemetrexed—SLC29A1—bronchus—chronic obstructive pulmonary disease	0.00715	0.024	CbGeAlD
Pemetrexed—DHFR—trachea—chronic obstructive pulmonary disease	0.00709	0.0238	CbGeAlD
Pemetrexed—DCK—bronchus—chronic obstructive pulmonary disease	0.00683	0.0229	CbGeAlD
Pemetrexed—SLC29A1—trachea—chronic obstructive pulmonary disease	0.00642	0.0216	CbGeAlD
Pemetrexed—DCK—trachea—chronic obstructive pulmonary disease	0.00614	0.0206	CbGeAlD
Pemetrexed—SLC46A1—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00532	0.0294	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.00518	0.0286	CbGpPWpGaD
Pemetrexed—TYMS—lung—chronic obstructive pulmonary disease	0.00515	0.0173	CbGeAlD
Pemetrexed—DHFR—lung—chronic obstructive pulmonary disease	0.0051	0.0171	CbGeAlD
Pemetrexed—SLC46A1—Iron uptake and transport—HMOX1—chronic obstructive pulmonary disease	0.00503	0.0278	CbGpPWpGaD
Pemetrexed—DHFR—Trans-sulfuration and one carbon metabolism—GCLC—chronic obstructive pulmonary disease	0.00494	0.0273	CbGpPWpGaD
Pemetrexed—SLC29A1—lung—chronic obstructive pulmonary disease	0.00462	0.0155	CbGeAlD
Pemetrexed—DCK—lung—chronic obstructive pulmonary disease	0.00441	0.0148	CbGeAlD
Pemetrexed—TYMS—Trans-sulfuration and one carbon metabolism—GCLC—chronic obstructive pulmonary disease	0.00431	0.0238	CbGpPWpGaD
Pemetrexed—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—NOS3—chronic obstructive pulmonary disease	0.0043	0.0237	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—SOD3—chronic obstructive pulmonary disease	0.00425	0.0235	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00398	0.022	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.00397	0.0219	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.00323	0.0178	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00309	0.0171	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism of nitric oxide—NOS3—chronic obstructive pulmonary disease	0.00298	0.0164	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—MPO—chronic obstructive pulmonary disease	0.00285	0.0157	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.0028	0.0154	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00275	0.0152	CbGpPWpGaD
Pemetrexed—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—chronic obstructive pulmonary disease	0.00264	0.0146	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00245	0.0135	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.00234	0.0129	CbGpPWpGaD
Pemetrexed—GART—Metabolism—APIP—chronic obstructive pulmonary disease	0.00218	0.0121	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00218	0.0121	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00215	0.0119	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.00214	0.0118	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.00207	0.0114	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00196	0.0109	CbGpPWpGaD
Pemetrexed—GART—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.00189	0.0104	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00349	CcSEcCtD
Pemetrexed—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00177	0.00348	CcSEcCtD
Pemetrexed—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.00177	0.00348	CcSEcCtD
Pemetrexed—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00176	0.00346	CcSEcCtD
Pemetrexed—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00176	0.00346	CcSEcCtD
Pemetrexed—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00176	0.00346	CcSEcCtD
Pemetrexed—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00346	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.00174	0.00963	CbGpPWpGaD
Pemetrexed—Shock—Aminophylline—chronic obstructive pulmonary disease	0.00174	0.00343	CcSEcCtD
Pemetrexed—Arthralgia—Tiotropium—chronic obstructive pulmonary disease	0.00174	0.00343	CcSEcCtD
Pemetrexed—Chest pain—Tiotropium—chronic obstructive pulmonary disease	0.00174	0.00343	CcSEcCtD
Pemetrexed—Myalgia—Tiotropium—chronic obstructive pulmonary disease	0.00174	0.00343	CcSEcCtD
Pemetrexed—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00174	0.00342	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00173	0.00341	CcSEcCtD
Pemetrexed—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00334	CcSEcCtD
Pemetrexed—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00334	CcSEcCtD
Pemetrexed—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00169	0.00332	CcSEcCtD
Pemetrexed—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00169	0.00332	CcSEcCtD
Pemetrexed—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.0033	CcSEcCtD
Pemetrexed—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00167	0.00329	CcSEcCtD
Pemetrexed—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00329	CcSEcCtD
Pemetrexed—Infection—Tiotropium—chronic obstructive pulmonary disease	0.00166	0.00327	CcSEcCtD
Pemetrexed—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00325	CcSEcCtD
Pemetrexed—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00325	CcSEcCtD
Pemetrexed—Shock—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00323	CcSEcCtD
Pemetrexed—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00164	0.00322	CcSEcCtD
Pemetrexed—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00162	0.00319	CcSEcCtD
Pemetrexed—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.00162	0.00318	CcSEcCtD
Pemetrexed—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.00162	0.00318	CcSEcCtD
Pemetrexed—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00315	CcSEcCtD
Pemetrexed—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00158	0.0031	CcSEcCtD
Pemetrexed—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.00307	CcSEcCtD
Pemetrexed—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00156	0.00307	CcSEcCtD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.00154	0.00851	CbGpPWpGaD
Pemetrexed—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00154	0.00303	CcSEcCtD
Pemetrexed—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.00153	0.00301	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00299	CcSEcCtD
Pemetrexed—ATIC—Metabolism—APIP—chronic obstructive pulmonary disease	0.00151	0.00836	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—CRP—chronic obstructive pulmonary disease	0.0015	0.00828	CbGpPWpGaD
Pemetrexed—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00147	0.00289	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00285	CcSEcCtD
Pemetrexed—GART—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00145	0.00799	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00144	0.00284	CcSEcCtD
Pemetrexed—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00143	0.00281	CcSEcCtD
Pemetrexed—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00143	0.00281	CcSEcCtD
Pemetrexed—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00143	0.00281	CcSEcCtD
Pemetrexed—Skin exfoliation—Prednisone—chronic obstructive pulmonary disease	0.00142	0.00279	CcSEcCtD
Pemetrexed—Mood swings—Prednisolone—chronic obstructive pulmonary disease	0.00141	0.00277	CcSEcCtD
Pemetrexed—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00141	0.00277	CcSEcCtD
Pemetrexed—GART—Metabolism—GC—chronic obstructive pulmonary disease	0.00141	0.00777	CbGpPWpGaD
Pemetrexed—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00277	CcSEcCtD
Pemetrexed—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00277	CcSEcCtD
Pemetrexed—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00277	CcSEcCtD
Pemetrexed—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00277	CcSEcCtD
Pemetrexed—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.00141	0.00277	CcSEcCtD
Pemetrexed—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00141	0.00277	CcSEcCtD
Pemetrexed—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00276	CcSEcCtD
Pemetrexed—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0014	0.00276	CcSEcCtD
Pemetrexed—Syncope—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00275	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00275	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00275	CcSEcCtD
Pemetrexed—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.0014	0.00275	CcSEcCtD
Pemetrexed—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00271	CcSEcCtD
Pemetrexed—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00271	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.00137	0.00758	CbGpPWpGaD
Pemetrexed—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.0027	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00269	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00137	0.00269	CcSEcCtD
Pemetrexed—Oesophagitis—Prednisone—chronic obstructive pulmonary disease	0.00136	0.00267	CcSEcCtD
Pemetrexed—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00265	CcSEcCtD
Pemetrexed—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00265	CcSEcCtD
Pemetrexed—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00265	CcSEcCtD
Pemetrexed—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00265	CcSEcCtD
Pemetrexed—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00135	0.00265	CcSEcCtD
Pemetrexed—Infection—Formoterol—chronic obstructive pulmonary disease	0.00134	0.00264	CcSEcCtD
Pemetrexed—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00134	0.00264	CcSEcCtD
Pemetrexed—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00261	CcSEcCtD
Pemetrexed—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00261	CcSEcCtD
Pemetrexed—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00261	CcSEcCtD
Pemetrexed—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00133	0.00261	CcSEcCtD
Pemetrexed—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00132	0.0026	CcSEcCtD
Pemetrexed—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00132	0.0026	CcSEcCtD
Pemetrexed—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00132	0.0026	CcSEcCtD
Pemetrexed—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00132	0.0026	CcSEcCtD
Pemetrexed—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00132	0.0026	CcSEcCtD
Pemetrexed—Infection—Montelukast—chronic obstructive pulmonary disease	0.00131	0.00258	CcSEcCtD
Pemetrexed—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00131	0.00258	CcSEcCtD
Pemetrexed—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00131	0.00258	CcSEcCtD
Pemetrexed—GART—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00131	0.00722	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.0013	0.00257	CcSEcCtD
Pemetrexed—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00255	CcSEcCtD
Pemetrexed—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00129	0.00254	CcSEcCtD
Pemetrexed—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.00129	0.00254	CcSEcCtD
Pemetrexed—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00128	0.00252	CcSEcCtD
Pemetrexed—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.0025	CcSEcCtD
Pemetrexed—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.0025	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.00127	0.00699	CbGpPWpGaD
Pemetrexed—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00249	CcSEcCtD
Pemetrexed—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00248	CcSEcCtD
Pemetrexed—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00247	CcSEcCtD
Pemetrexed—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00246	CcSEcCtD
Pemetrexed—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00246	CcSEcCtD
Pemetrexed—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00124	0.00243	CcSEcCtD
Pemetrexed—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00123	0.00242	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00242	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00242	CcSEcCtD
Pemetrexed—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00239	CcSEcCtD
Pemetrexed—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00238	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.0012	0.00237	CcSEcCtD
Pemetrexed—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00237	CcSEcCtD
Pemetrexed—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00237	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—PLAU—chronic obstructive pulmonary disease	0.0012	0.00662	CbGpPWpGaD
Pemetrexed—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00234	CcSEcCtD
Pemetrexed—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00234	CcSEcCtD
Pemetrexed—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00118	0.00233	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00118	0.00651	CbGpPWpGaD
Pemetrexed—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00117	0.00231	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00229	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00229	CcSEcCtD
Pemetrexed—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00229	CcSEcCtD
Pemetrexed—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00116	0.00229	CcSEcCtD
Pemetrexed—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00116	0.00229	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00228	CcSEcCtD
Pemetrexed—Pain—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00227	CcSEcCtD
Pemetrexed—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00227	CcSEcCtD
Pemetrexed—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00227	CcSEcCtD
Pemetrexed—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00227	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	0.00115	0.00636	CbGpPWpGaD
Pemetrexed—DHFR—Folate Metabolism—ALB—chronic obstructive pulmonary disease	0.00115	0.00635	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00224	CcSEcCtD
Pemetrexed—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00114	0.00224	CcSEcCtD
Pemetrexed—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00223	CcSEcCtD
Pemetrexed—Pain—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00222	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00113	0.00222	CcSEcCtD
Pemetrexed—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00113	0.00222	CcSEcCtD
Pemetrexed—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00221	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00221	CcSEcCtD
Pemetrexed—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00221	CcSEcCtD
Pemetrexed—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.0022	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.00112	0.00616	CbGpPWpGaD
Pemetrexed—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.0022	CcSEcCtD
Pemetrexed—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00111	0.00219	CcSEcCtD
Pemetrexed—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00218	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00111	0.0835	CbGdCrCtD
Pemetrexed—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00217	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00217	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00217	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00216	CcSEcCtD
Pemetrexed—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.0011	0.00216	CcSEcCtD
Pemetrexed—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00214	CcSEcCtD
Pemetrexed—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00214	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00212	CcSEcCtD
Pemetrexed—DCK—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.0815	CbGdCrCtD
Pemetrexed—DCK—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00107	0.0811	CbGdCrCtD
Pemetrexed—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00211	CcSEcCtD
Pemetrexed—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00211	CcSEcCtD
Pemetrexed—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0021	CcSEcCtD
Pemetrexed—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0021	CcSEcCtD
Pemetrexed—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00107	0.0021	CcSEcCtD
Pemetrexed—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.0021	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.00106	0.00587	CbGpPWpGaD
Pemetrexed—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00106	0.00209	CcSEcCtD
Pemetrexed—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00207	CcSEcCtD
Pemetrexed—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00105	0.00207	CcSEcCtD
Pemetrexed—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00207	CcSEcCtD
Pemetrexed—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00206	CcSEcCtD
Pemetrexed—DCK—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00105	0.0791	CbGdCrCtD
Pemetrexed—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00205	CcSEcCtD
Pemetrexed—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00104	0.00205	CcSEcCtD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.00104	0.00575	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00205	CcSEcCtD
Pemetrexed—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00201	CcSEcCtD
Pemetrexed—SLC46A1—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.00102	0.00564	CbGpPWpGaD
Pemetrexed—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00199	CcSEcCtD
Pemetrexed—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00198	CcSEcCtD
Pemetrexed—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00198	CcSEcCtD
Pemetrexed—ATIC—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.001	0.00554	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000993	0.00195	CcSEcCtD
Pemetrexed—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000993	0.00195	CcSEcCtD
Pemetrexed—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000992	0.00195	CcSEcCtD
Pemetrexed—ATIC—Metabolism—GC—chronic obstructive pulmonary disease	0.000975	0.00539	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000972	0.00191	CcSEcCtD
Pemetrexed—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000967	0.0019	CcSEcCtD
Pemetrexed—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000967	0.0019	CcSEcCtD
Pemetrexed—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000953	0.00188	CcSEcCtD
Pemetrexed—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000953	0.00188	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000952	0.00187	CcSEcCtD
Pemetrexed—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000947	0.00186	CcSEcCtD
Pemetrexed—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000937	0.00185	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	0.000935	0.00517	CbGpPWpGaD
Pemetrexed—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000934	0.00184	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000927	0.00512	CbGpPWpGaD
Pemetrexed—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000922	0.00182	CcSEcCtD
Pemetrexed—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000922	0.00182	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000921	0.00509	CbGpPWpGaD
Pemetrexed—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000918	0.00181	CcSEcCtD
Pemetrexed—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000914	0.0018	CcSEcCtD
Pemetrexed—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000913	0.0018	CcSEcCtD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000909	0.00502	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000906	0.00501	CbGpPWpGaD
Pemetrexed—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000903	0.00178	CcSEcCtD
Pemetrexed—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.0009	0.00177	CcSEcCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisone—chronic obstructive pulmonary disease	0.000897	0.0678	CbGdCrCtD
Pemetrexed—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000894	0.00176	CcSEcCtD
Pemetrexed—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000891	0.00175	CcSEcCtD
Pemetrexed—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000891	0.00175	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.000885	0.0669	CbGdCrCtD
Pemetrexed—TYMS—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.000876	0.0662	CbGdCrCtD
Pemetrexed—TYMS—Clobetasol propionate—Prednisolone—chronic obstructive pulmonary disease	0.000875	0.0662	CbGdCrCtD
Pemetrexed—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000873	0.00172	CcSEcCtD
Pemetrexed—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000872	0.00172	CcSEcCtD
Pemetrexed—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000871	0.00171	CcSEcCtD
Pemetrexed—TYMS—Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.000864	0.0653	CbGdCrCtD
Pemetrexed—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000857	0.00169	CcSEcCtD
Pemetrexed—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000857	0.00169	CcSEcCtD
Pemetrexed—TYMS—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.000855	0.0646	CbGdCrCtD
Pemetrexed—Rash—Formoterol—chronic obstructive pulmonary disease	0.00085	0.00167	CcSEcCtD
Pemetrexed—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00085	0.00167	CcSEcCtD
Pemetrexed—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000849	0.00167	CcSEcCtD
Pemetrexed—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000849	0.00167	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000845	0.00467	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000842	0.00465	CbGpPWpGaD
Pemetrexed—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000841	0.00166	CcSEcCtD
Pemetrexed—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000839	0.00165	CcSEcCtD
Pemetrexed—Rash—Montelukast—chronic obstructive pulmonary disease	0.000832	0.00164	CcSEcCtD
Pemetrexed—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000831	0.00164	CcSEcCtD
Pemetrexed—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.00082	0.00161	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000815	0.0016	CcSEcCtD
Pemetrexed—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000815	0.0016	CcSEcCtD
Pemetrexed—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000809	0.00159	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.000808	0.061	CbGdCrCtD
Pemetrexed—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000802	0.00158	CcSEcCtD
Pemetrexed—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000802	0.00158	CcSEcCtD
Pemetrexed—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000802	0.00158	CcSEcCtD
Pemetrexed—Nausea—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00158	CcSEcCtD
Pemetrexed—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00158	CcSEcCtD
Pemetrexed—TYMS—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.000788	0.0596	CbGdCrCtD
Pemetrexed—DCK—Metabolism—APIP—chronic obstructive pulmonary disease	0.000786	0.00434	CbGpPWpGaD
Pemetrexed—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000786	0.00155	CcSEcCtD
Pemetrexed—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000784	0.00154	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000781	0.00431	CbGpPWpGaD
Pemetrexed—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000772	0.00152	CcSEcCtD
Pemetrexed—GART—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000768	0.00424	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000759	0.0042	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000759	0.0042	CbGpPWpGaD
Pemetrexed—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000756	0.00149	CcSEcCtD
Pemetrexed—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.00073	0.00144	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00073	0.00144	CcSEcCtD
Pemetrexed—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000718	0.00141	CcSEcCtD
Pemetrexed—TYMS—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.000708	0.0535	CbGdCrCtD
Pemetrexed—SLC46A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000706	0.0039	CbGpPWpGaD
Pemetrexed—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000698	0.00137	CcSEcCtD
Pemetrexed—GART—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000693	0.00383	CbGpPWpGaD
Pemetrexed—TYMS—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.000691	0.0522	CbGdCrCtD
Pemetrexed—DHFR—Folate Metabolism—TNF—chronic obstructive pulmonary disease	0.000679	0.00375	CbGpPWpGaD
Pemetrexed—TYMS—Danazol—Prednisone—chronic obstructive pulmonary disease	0.000678	0.0513	CbGdCrCtD
Pemetrexed—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000667	0.00131	CcSEcCtD
Pemetrexed—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.00066	0.0013	CcSEcCtD
Pemetrexed—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.00065	0.00128	CcSEcCtD
Pemetrexed—Erythema—Prednisone—chronic obstructive pulmonary disease	0.00065	0.00128	CcSEcCtD
Pemetrexed—GART—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000638	0.00353	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—APIP—chronic obstructive pulmonary disease	0.000632	0.00349	CbGpPWpGaD
Pemetrexed—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000624	0.00123	CcSEcCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000606	0.00335	CbGpPWpGaD
Pemetrexed—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000601	0.00118	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—TP53—chronic obstructive pulmonary disease	0.000598	0.0033	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000597	0.0033	CbGpPWpGaD
Pemetrexed—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000583	0.00115	CcSEcCtD
Pemetrexed—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00058	0.00114	CcSEcCtD
Pemetrexed—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000571	0.00112	CcSEcCtD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000567	0.00313	CbGpPWpGaD
Pemetrexed—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000561	0.0011	CcSEcCtD
Pemetrexed—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000553	0.00109	CcSEcCtD
Pemetrexed—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000553	0.00109	CcSEcCtD
Pemetrexed—TYMS—Metabolism—APIP—chronic obstructive pulmonary disease	0.000551	0.00305	CbGpPWpGaD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000549	0.00108	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—IL6—chronic obstructive pulmonary disease	0.000548	0.00303	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000538	0.00106	CcSEcCtD
Pemetrexed—ATIC—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000533	0.00294	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000533	0.00294	CbGpPWpGaD
Pemetrexed—Oedema—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00104	CcSEcCtD
Pemetrexed—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00053	0.00104	CcSEcCtD
Pemetrexed—Infection—Prednisone—chronic obstructive pulmonary disease	0.000527	0.00104	CcSEcCtD
Pemetrexed—ATIC—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000526	0.00291	CbGpPWpGaD
Pemetrexed—GART—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000525	0.0029	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000525	0.0029	CbGpPWpGaD
Pemetrexed—Shock—Prednisone—chronic obstructive pulmonary disease	0.000522	0.00103	CcSEcCtD
Pemetrexed—DCK—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000521	0.00288	CbGpPWpGaD
Pemetrexed—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.00052	0.00102	CcSEcCtD
Pemetrexed—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000515	0.00101	CcSEcCtD
Pemetrexed—DCK—Metabolism—GC—chronic obstructive pulmonary disease	0.000507	0.0028	CbGpPWpGaD
Pemetrexed—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000506	0.000995	CcSEcCtD
Pemetrexed—GART—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000489	0.0027	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000489	0.0027	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000951	CcSEcCtD
Pemetrexed—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000483	0.00095	CcSEcCtD
Pemetrexed—ATIC—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00048	0.00265	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.00048	0.00265	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.00048	0.00265	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000471	0.0026	CbGpPWpGaD
Pemetrexed—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000467	0.000919	CcSEcCtD
Pemetrexed—GART—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000464	0.00256	CbGpPWpGaD
Pemetrexed—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000461	0.000908	CcSEcCtD
Pemetrexed—Rash—Prednisolone—chronic obstructive pulmonary disease	0.00046	0.000906	CcSEcCtD
Pemetrexed—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00046	0.000905	CcSEcCtD
Pemetrexed—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000457	0.0009	CcSEcCtD
Pemetrexed—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000893	CcSEcCtD
Pemetrexed—ATIC—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000443	0.00245	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000434	0.000854	CcSEcCtD
Pemetrexed—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000433	0.000853	CcSEcCtD
Pemetrexed—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000829	CcSEcCtD
Pemetrexed—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000825	CcSEcCtD
Pemetrexed—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000419	0.000825	CcSEcCtD
Pemetrexed—DHFR—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000419	0.00231	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000418	0.00231	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HDAC2—chronic obstructive pulmonary disease	0.000416	0.0023	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000415	0.00229	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000412	0.00228	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00041	0.00227	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GC—chronic obstructive pulmonary disease	0.000407	0.00225	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000391	0.000769	CcSEcCtD
Pemetrexed—SLC46A1—Disease—KL—chronic obstructive pulmonary disease	0.000387	0.00214	CbGpPWpGaD
Pemetrexed—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00038	0.000749	CcSEcCtD
Pemetrexed—DHFR—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000379	0.00209	CbGpPWpGaD
Pemetrexed—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000375	0.000739	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000374	0.00207	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000369	0.00204	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000365	0.00202	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000364	0.00201	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000364	0.00201	CbGpPWpGaD
Pemetrexed—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000363	0.000714	CcSEcCtD
Pemetrexed—TYMS—Metabolism—GC—chronic obstructive pulmonary disease	0.000355	0.00196	CbGpPWpGaD
Pemetrexed—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000351	0.00069	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000345	0.0019	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000339	0.00187	CbGpPWpGaD
Pemetrexed—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000337	0.000664	CcSEcCtD
Pemetrexed—Rash—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000658	CcSEcCtD
Pemetrexed—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000334	0.000658	CcSEcCtD
Pemetrexed—TYMS—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00033	0.00182	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000322	0.00178	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ALB—chronic obstructive pulmonary disease	0.000315	0.00174	CbGpPWpGaD
Pemetrexed—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00062	CcSEcCtD
Pemetrexed—GART—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000302	0.00167	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000295	0.00163	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB3—chronic obstructive pulmonary disease	0.00029	0.0016	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000288	0.00159	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000288	0.00159	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000284	0.00157	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000277	0.00153	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000274	0.00151	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000271	0.0015	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000266	0.00147	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000264	0.00146	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000253	0.0014	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000251	0.00138	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00025	0.00138	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS2—chronic obstructive pulmonary disease	0.000242	0.00134	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00023	0.00127	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HDAC2—chronic obstructive pulmonary disease	0.000223	0.00123	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000223	0.00123	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000222	0.00123	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00022	0.00121	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ALB—chronic obstructive pulmonary disease	0.000219	0.00121	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.000214	0.00118	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000209	0.00116	CbGpPWpGaD
Pemetrexed—DHFR—Disease—KL—chronic obstructive pulmonary disease	0.000208	0.00115	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000204	0.00113	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000201	0.00111	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000196	0.00108	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NOS3—chronic obstructive pulmonary disease	0.000194	0.00107	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000194	0.00107	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000192	0.00106	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000192	0.00106	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000189	0.00105	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000185	0.00102	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000176	0.000974	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000175	0.000967	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ALB—chronic obstructive pulmonary disease	0.00017	0.000941	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000167	0.000923	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000163	0.0009	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000161	0.000891	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB3—chronic obstructive pulmonary disease	0.000156	0.00086	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000154	0.000852	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000152	0.00084	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000142	0.000783	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000135	0.000743	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000134	0.000742	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000133	0.000733	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS2—chronic obstructive pulmonary disease	0.00013	0.000717	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—TGFB1—chronic obstructive pulmonary disease	0.000129	0.000711	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—EGFR—chronic obstructive pulmonary disease	0.000126	0.000697	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000124	0.000683	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000117	0.000648	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ALB—chronic obstructive pulmonary disease	0.000114	0.000628	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000111	0.000611	CbGpPWpGaD
Pemetrexed—DHFR—Disease—SERPINE1—chronic obstructive pulmonary disease	0.000109	0.000603	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000109	0.0006	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NOS3—chronic obstructive pulmonary disease	0.000104	0.000576	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—IL6—chronic obstructive pulmonary disease	9.69e-05	0.000535	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—chronic obstructive pulmonary disease	9.66e-05	0.000533	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ALB—chronic obstructive pulmonary disease	9.13e-05	0.000504	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—NOS3—chronic obstructive pulmonary disease	8.73e-05	0.000483	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ALB—chronic obstructive pulmonary disease	7.97e-05	0.00044	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—NOS3—chronic obstructive pulmonary disease	7.62e-05	0.000421	CbGpPWpGaD
Pemetrexed—DHFR—Disease—TGFB1—chronic obstructive pulmonary disease	6.9e-05	0.000381	CbGpPWpGaD
Pemetrexed—DHFR—Disease—EGFR—chronic obstructive pulmonary disease	6.76e-05	0.000374	CbGpPWpGaD
Pemetrexed—DHFR—Disease—IL6—chronic obstructive pulmonary disease	5.2e-05	0.000287	CbGpPWpGaD
